Drug Type Monoclonal antibody |
Synonyms SHR 1703 |
Target |
Mechanism IL-5 inhibitors(Interleukin-5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2/3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Churg-Strauss Syndrome | Phase 3 | CN | 16 Nov 2023 | |
Churg-Strauss Syndrome | Phase 3 | CN | 16 Nov 2023 | |
Asthma | Phase 2 | CN | 22 Dec 2022 | |
Eosinophilic Asthma | Phase 2 | CN | 22 Dec 2022 |